As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.

T-cell therapy is the most efficacious approach for many patients with relapsed/refractory multiple myeloma, but it currently comes with 2 periods ...

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles ...

A new analytical method could improve how cancer treatments are designed - by allowing scientists to track, for the first time, exactly where inside a living cell a drug accumulates. Researchers from ...

Solid-state batteries have been the electric vehicle industry's most coveted prize for the better part of a decade. The ...

Police have identified the man arrested in the shooting of a woman caught on camera in Coral Springs, saying the act of ...

Because many password generators aren't as random as they seem, I built an improved one in Excel—and I'll show you exactly ...

UCSF research led to the world’s first immunotherapy to prevent type 1 diabetes. Now, scientists are aiming for the ‘holy ...

Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...

This manuscript reports an important study in which the authors apply smFRET imaging to probe HIV-1 Env conformational dynamics in the presence of antibodies. Previous implementations of smFRET ...

A cancer cell begins to die, and for the first time, a researcher can watch the exact moment it happens. New fluorescent dyes ...

New research shows the common cold virus may stay hidden in the body and spread without symptoms long after recovery.